IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,753,000 | +19.1% | 55,372 | +23.8% | 0.01% | -22.2% |
| Q3 2020 | $1,472,000 | -84.0% | 44,724 | -86.6% | 0.01% | -85.2% |
| Q2 2020 | $9,173,000 | +253.1% | 334,172 | +285.0% | 0.06% | +205.0% |
| Q1 2020 | $2,598,000 | +960.4% | 86,803 | +881.0% | 0.02% | +1900.0% |
| Q4 2019 | $245,000 | -95.2% | 8,848 | -95.8% | 0.00% | -96.9% |
| Q2 2019 | $5,153,000 | -14.1% | 210,174 | -66.7% | 0.03% | +52.4% |
| Q1 2019 | $6,002,000 | +895.4% | 630,898 | +826.0% | 0.02% | +250.0% |
| Q4 2018 | $603,000 | -87.4% | 68,128 | -84.0% | 0.01% | -62.5% |
| Q3 2018 | $4,796,000 | -30.3% | 426,364 | -20.7% | 0.02% | -59.0% |
| Q2 2018 | $6,882,000 | -75.7% | 537,668 | -68.0% | 0.04% | -72.5% |
| Q1 2018 | $28,375,000 | +30742.4% | 1,678,971 | +12628.2% | 0.14% | +14100.0% |
| Q2 2017 | $92,000 | – | 13,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |